000 01781 a2200481 4500
005 20250517052805.0
264 0 _c20160920
008 201609s 0 0 eng d
022 _a1878-1705
024 7 _a10.1016/j.intimp.2015.08.030
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPark, Ki Hwan
245 0 0 _aHypothemycin inhibits tumor necrosis factor-α production by tristetraprolin-dependent down-regulation of mRNA stability in lipopolysaccharide-stimulated macrophages.
_h[electronic resource]
260 _bInternational immunopharmacology
_cDec 2015
300 _a863-868 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aADAM Proteins
_xdrug effects
650 0 4 _aADAM17 Protein
650 0 4 _aAnimals
650 0 4 _aDown-Regulation
_xdrug effects
650 0 4 _aHumans
650 0 4 _aLipopolysaccharides
_xpharmacology
650 0 4 _aMacrophages
_xdrug effects
650 0 4 _aMice
650 0 4 _aNitric Oxide
_xbiosynthesis
650 0 4 _aRAW 264.7 Cells
650 0 4 _aRNA Stability
_xdrug effects
650 0 4 _aTristetraprolin
_xpharmacology
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
650 0 4 _aZearalenone
_xanalogs & derivatives
650 0 4 _ap38 Mitogen-Activated Protein Kinases
_xantagonists & inhibitors
700 1 _aYoon, Yeo Dae
700 1 _aKang, Moo Rim
700 1 _aYun, Jieun
700 1 _aOh, Soo Jin
700 1 _aLee, Chang Woo
700 1 _aLee, Myeong Youl
700 1 _aHan, Sang-Bae
700 1 _aKim, Youngsoo
700 1 _aKang, Jong Soon
773 0 _tInternational immunopharmacology
_gvol. 29
_gno. 2
_gp. 863-868
856 4 0 _uhttps://doi.org/10.1016/j.intimp.2015.08.030
_zAvailable from publisher's website
999 _c25263157
_d25263157